110 related articles for article (PubMed ID: 30063826)
21. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2008)].
Goto H; Iwasaki M
Jpn J Antibiot; 2015 Feb; 68(1):19-36. PubMed ID: 25980051
[TBL] [Abstract][Full Text] [Related]
24. Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.
Reck F; Alm RA; Brassil P; Newman JV; Ciaccio P; McNulty J; Barthlow H; Goteti K; Breen J; Comita-Prevoir J; Cronin M; Ehmann DE; Geng B; Godfrey AA; Fisher SL
J Med Chem; 2012 Aug; 55(15):6916-33. PubMed ID: 22779424
[TBL] [Abstract][Full Text] [Related]
25. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antibacterial evaluation of novel pleuromutilin derivatives.
Shang R; Liu Y; Xin Z; Guo W; Guo Z; Hao B; Jianping L
Eur J Med Chem; 2013 May; 63():231-8. PubMed ID: 23501109
[TBL] [Abstract][Full Text] [Related]
27. Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Ushiyama F; Amada H; Mihara Y; Takeuchi T; Tanaka-Yamamoto N; Mima M; Kamitani M; Wada R; Tamura Y; Endo M; Masuko A; Takata I; Hitaka K; Sugiyama H; Ohtake N
Bioorg Med Chem; 2020 Nov; 28(22):115776. PubMed ID: 33032189
[TBL] [Abstract][Full Text] [Related]
28. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
Li L; Okumu A; Dellos-Nolan S; Li Z; Karmahapatra S; English A; Yalowich JC; Wozniak DJ; Mitton-Fry MJ
Bioorg Med Chem Lett; 2018 Aug; 28(14):2477-2480. PubMed ID: 29871847
[TBL] [Abstract][Full Text] [Related]
30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
33. Novel C-4'' modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: the synthesis and antimicrobial evaluation.
Ma X; Zhang L; Wang R; Cao J; Liu C; Fang Y; Wang J; Ma S
Eur J Med Chem; 2011 Oct; 46(10):5196-205. PubMed ID: 21855183
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
[TBL] [Abstract][Full Text] [Related]
37. Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
Pfaller MA; Mendes RE; Castanheira M; Flamm RK; Jones RN; Sader HS
Pediatr Infect Dis J; 2017 May; 36(5):486-491. PubMed ID: 28403050
[TBL] [Abstract][Full Text] [Related]
38. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
39. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.
Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE
Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
